Cystic fibrosis

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current opinion in pulmonary medicine 1999-11, Vol.5 (6), p.363-363
1. Verfasser:	Shapiro, Bertrand J
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - therapeutic use Cystic Fibrosis - genetics Cystic Fibrosis - therapy Diabetes Complications Genetic Therapy Humans Lung Transplantation Survival Rate
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	363
container_issue	6
container_start_page	363
container_title	Current opinion in pulmonary medicine
container_volume	5
creator	Shapiro, Bertrand J
description
doi_str_mv	10.1097/00063198-199911000-00007
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69295880</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69295880</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2167-1d3824eeae59ebb38bd61f3163973ea15a92bd5a1231c47b7691e5bc96d5f7043</originalsourceid><addsrcrecordid>eNp1kEtPwzAMgCMEYmMg_gHaiVvBTprXEU28pElc4BwlrasVOjqaVtP-PYEOxIWDZVv67MQfY3OEKwSrrwFACbQmQ2stYmqzFKAP2BSlwExZjYepBg2Z5EZP2EmMrwDIE33MJghSgxZ6ys4Xu9jXxbyqQ9fGOp6yo8o3kc72ecZe7m6fFw_Z8un-cXGzzAqOSmdYCsNzIk_SUgjChFJhJVAJqwV5lN7yUEqPXGCR66CVRZKhsKqUlYZczNjluHfTtR8Dxd6t61hQ0_h3aofolOVWGgMJNCNYpP_Fjiq36eq173YOwX3JcD8y3K8M9y0jjV7s3xjCmso_g-P1CchHYNs2PXXxrRm21LkV-aZfuf8ki0_CWWcU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69295880</pqid></control><display><type>article</type><title>Cystic fibrosis</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Shapiro, Bertrand J</creator><creatorcontrib>Shapiro, Bertrand J</creatorcontrib><identifier>ISSN: 1070-5287</identifier><identifier>EISSN: 1531-6971</identifier><identifier>DOI: 10.1097/00063198-199911000-00007</identifier><identifier>PMID: 10570737</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins, Inc</publisher><subject>Anti-Bacterial Agents - therapeutic use ; Cystic Fibrosis - genetics ; Cystic Fibrosis - therapy ; Diabetes Complications ; Genetic Therapy ; Humans ; Lung Transplantation ; Survival Rate</subject><ispartof>Current opinion in pulmonary medicine, 1999-11, Vol.5 (6), p.363-363</ispartof><rights>1999 Lippincott Williams & Wilkins, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2167-1d3824eeae59ebb38bd61f3163973ea15a92bd5a1231c47b7691e5bc96d5f7043</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10570737$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shapiro, Bertrand J</creatorcontrib><title>Cystic fibrosis</title><title>Current opinion in pulmonary medicine</title><addtitle>Curr Opin Pulm Med</addtitle><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis - therapy</subject><subject>Diabetes Complications</subject><subject>Genetic Therapy</subject><subject>Humans</subject><subject>Lung Transplantation</subject><subject>Survival Rate</subject><issn>1070-5287</issn><issn>1531-6971</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEtPwzAMgCMEYmMg_gHaiVvBTprXEU28pElc4BwlrasVOjqaVtP-PYEOxIWDZVv67MQfY3OEKwSrrwFACbQmQ2stYmqzFKAP2BSlwExZjYepBg2Z5EZP2EmMrwDIE33MJghSgxZ6ys4Xu9jXxbyqQ9fGOp6yo8o3kc72ecZe7m6fFw_Z8un-cXGzzAqOSmdYCsNzIk_SUgjChFJhJVAJqwV5lN7yUEqPXGCR66CVRZKhsKqUlYZczNjluHfTtR8Dxd6t61hQ0_h3aofolOVWGgMJNCNYpP_Fjiq36eq173YOwX3JcD8y3K8M9y0jjV7s3xjCmso_g-P1CchHYNs2PXXxrRm21LkV-aZfuf8ki0_CWWcU</recordid><startdate>199911</startdate><enddate>199911</enddate><creator>Shapiro, Bertrand J</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199911</creationdate><title>Cystic fibrosis</title><author>Shapiro, Bertrand J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2167-1d3824eeae59ebb38bd61f3163973ea15a92bd5a1231c47b7691e5bc96d5f7043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis - therapy</topic><topic>Diabetes Complications</topic><topic>Genetic Therapy</topic><topic>Humans</topic><topic>Lung Transplantation</topic><topic>Survival Rate</topic><toplevel>online_resources</toplevel><creatorcontrib>Shapiro, Bertrand J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in pulmonary medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shapiro, Bertrand J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cystic fibrosis</atitle><jtitle>Current opinion in pulmonary medicine</jtitle><addtitle>Curr Opin Pulm Med</addtitle><date>1999-11</date><risdate>1999</risdate><volume>5</volume><issue>6</issue><spage>363</spage><epage>363</epage><pages>363-363</pages><issn>1070-5287</issn><eissn>1531-6971</eissn><cop>United States</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>10570737</pmid><doi>10.1097/00063198-199911000-00007</doi><tpages>1</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1070-5287
ispartof	Current opinion in pulmonary medicine, 1999-11, Vol.5 (6), p.363-363
issn	1070-5287 1531-6971
language	eng
recordid	cdi_proquest_miscellaneous_69295880
source	MEDLINE; Journals@Ovid Complete
subjects	Anti-Bacterial Agents - therapeutic use Cystic Fibrosis - genetics Cystic Fibrosis - therapy Diabetes Complications Genetic Therapy Humans Lung Transplantation Survival Rate
title	Cystic fibrosis
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A07%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cystic%20fibrosis&rft.jtitle=Current%20opinion%20in%20pulmonary%20medicine&rft.au=Shapiro,%20Bertrand%20J&rft.date=1999-11&rft.volume=5&rft.issue=6&rft.spage=363&rft.epage=363&rft.pages=363-363&rft.issn=1070-5287&rft.eissn=1531-6971&rft_id=info:doi/10.1097/00063198-199911000-00007&rft_dat=%3Cproquest_cross%3E69295880%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69295880&rft_id=info:pmid/10570737&rfr_iscdi=true